SMA Europe SMA Europe is a non-profit umbrella organisation of SMA patient organisations from across Europe.

07/08/2026

3, 2, 1... Rolling!

Could SMA begin affecting the nervous system earlier than we once thought?

In this interview, Lucia, a Rolling Journalist from Slovakia, speaks with Florian Gerstner, an Early Stage Researcher, about his work on cerebral pathology in SMA and emerging evidence that SMA may also have a neurodevelopmental component.

Watch the interview to discover why expanding our view of SMA is essential for advancing science and improving care.

06/08/2026

3, 2, 1... Rolling!

What happens in SMA before motor neurons are lost?

In this interview, Ilgaz, a Rolling Journalist from Türkiye, talks with Leonie Sowoidnich, an Early Stage Researcher, about research exploring the earliest changes in SMA.

Their conversation focuses on growing evidence that the loss of synapses may occur before the death of motor neurons, opening new perspectives on how the disease develops.

Understanding these early events is crucial. By identifying the first changes in SMA, researchers hope to uncover new opportunities for earlier intervention and more effective therapies that can protect nerve function before irreversible damage occurs.

05/08/2026

3, 2, 1... Rolling!

How can research into the brain help us better understand SMA?

In this interview, Ilgaz, a Rolling Journalist from Türkiye, speaks with Leonie Sowoidnich, an Early Stage Researcher, about her work exploring the link between dopamine dysregulation and spinal muscular atrophy, and how it may contribute to motor impairment and posture.

Watch the interview to discover how today’s scientific questions could shape tomorrow’s breakthroughs.

Are you working on research that could help advance understanding of SMA? 🔬Applications are open for SMA Europe’s 13th C...
04/08/2026

Are you working on research that could help advance understanding of SMA? 🔬

Applications are open for SMA Europe’s 13th Call for Research Proposals, supporting high-quality scientific projects that aim to improve knowledge, care, and outcomes for people living with SMA.

Researchers are encouraged to review the eligibility criteria and submit their proposals before the deadline.

Application deadline: 30 September 2026, 16:00 UTC+1.

More information is available here:
🔗 https://www.sma-europe.eu/our-call-for-research-proposals

04/08/2026

3, 2, 1... Rolling!

What should be the common goal for the years ahead in SMA?

In this conversation, Nadya, a Rolling Journalist from Russia, interviews Stefania Corti, Chair of SMA Europe’s Scientific Advisory Board, about the importance of listening to and understanding the real priorities of the SMA community.

Watch the interview and join the conversation about how we can shape a future driven by the priorities of the SMA community.

03/08/2026

3, 2, 1... Rolling!

What does personalised care really mean for people living with SMA?

In this interview, Nadya, a Rolling Journalist from Russia, speaks with Stefania Corti, Chair of SMA Europe’s Scientific Advisory Board, about the current state of personalised care in SMA, why every person’s journey is unique, and how research could help shape more individualised approaches to treatment and long-term care.

Watch the conversation and discover why personalised care is key to improving quality of life for everyone living with SMA.

01/08/2026

Following this morning’s launch of 3, 2, 1... Rolling!, we are taking you for an additional conversation with Jakub, parent advocate and Board Member at SMA Europe.

Jakub shares why SMA research remains absolutely vital, even as transformative treatments continue to change the lives of people living with SMA.

Although newborn screening can enable children to begin treatment very early, questions about their future outcomes remain. Continued research is essential to deepen our understanding of SMA, improve existing treatments, and develop the best possible approaches to care.

Jakub also highlights the importance of continuing to support experienced researchers while inspiring young scientists to bring their knowledge, passion, and careers to SMA research.

Watch this special moment and hear why progress in SMA research must continue. 💜

01/08/2026

Today, 1 August, the SMA Europe cameras start rolling. 🎥

3, 2, 1... Rolling! is our awareness campaign, created together with the Rolling Journalists, young people living with spinal muscular atrophy (SMA).

Over the next few weeks, we will share the stories, voices, and perspectives that matter most to our SMA community.

While transformative treatments have changed the lives of many people living with SMA, research remains the driving force behind better therapies, earlier diagnosis, more personalised care, and ultimately, a future where a cure is possible.

As Olga Germanenko, Vice-President of the Board at SMA Europe, says:

“Supporting fundamental research is critical. It lays the necessary foundation for developing new drugs, improving diagnostic methods, and finding ways to completely cure the disease. Fundamental science helps identify molecular markers that in the future can accurately predict the course of the disease and assess the effectiveness of treatment for each patient.

The discovery of the mechanisms being studied for SMA also provides the scientific basis for the search for treatments for other severe neurodegenerative and genetic diseases.

Continuing to support and fund fundamental research is essential today. The more we invest in supporting basic research today, the more progress we will see tomorrow and, perhaps, the closer we will get to the currently elusive goal of a complete cure.”

This is just the beginning. Over the coming weeks, we will bring you conversations with researchers, clinicians, advocates, and people living with SMA to explore why research matters and why continued investment is essential for the future of our SMA community.

3, 2, 1... Rolling!

Join our upcoming SMAcademy webinar: “Long-term responses to disease-modifying treatments in SMA”🗓️ 15 September 2026⏰ 1...
31/07/2026

Join our upcoming SMAcademy webinar: “Long-term responses to disease-modifying treatments in SMA”

🗓️ 15 September 2026
⏰ 17:00–18:30 CEST

The webinar will feature Tina Duong, MPT, PhD, a senior research scientist and physical therapist specialising in neuromuscular clinical research and the development of innovative outcome measures.

As increasing numbers of people living with SMA receive disease-modifying treatments, understanding their long-term effectiveness and durability is becoming increasingly important.

Drawing on evidence from large international real-world studies, this session will explore:

✔️ What long-term motor stabilisation means in clinical practice
✔️ How changes in motor function can be interpreted over time
✔️ Why multiple assessment tools are essential for evaluating outcomes across the full spectrum of SMA
✔️ What emerging evidence may mean for the future of SMA care

The webinar will support patient advocates in interpreting long-term treatment data and understanding both the benefits and ongoing challenges associated with disease-modifying treatments.

Register via the QR code or here:
https://www.sma-europe.eu/sm-academy-learning-opportunities-and-webinars

Together, 🌍

The EUPESMA Survey on SMA medicines, treatments and access journeys revealed persisting challenges for access to care an...
29/07/2026

The EUPESMA Survey on SMA medicines, treatments and access journeys revealed persisting challenges for access to care and continuity of treatment:

✔️ 15.0% of respondents had to move to a different country to access SMA care.
✔️ 19.5% stopped or interrupted treatment with an SMA medicine at least once.
✔️ 50.4% fear that they may be forced to stop treatment in the future.
✔️ Among untreated respondents, 52.8% have no access to disease-modifying therapies, despite these therapies being available in their country.

These findings show why availability alone is not enough. People living with SMA need timely, equitable and sustainable access to treatment throughout their lives, without being forced to relocate or fear losing their care.

Explore the findings in the new publication:
https://heyzine.com/flip-book/f9722b6437.html

Adresse

Im Moos 4
Freiburg Im Breisgau
79112

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von SMA Europe erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.

Die Praxis Kontaktieren

Nachricht an SMA Europe senden:

Verknüpfungen

Teilen